Health

Sarawak Allows Use of AstraZeneca Vaccine In Its Immunisation Rollout Plan

KUCHING, May 18 — The COVID-19 Immunisation Task Force of Sarawak (CITF Sarawak) has decided to allow the use of the AstraZeneca vaccine, which is now called Vaxzevria, to complement the state’s vaccination rollout plan.

In a statement today, it said the decision was made after it heard the review and presentation by the Sarawak COVID-19 Vaccine Advisory Group (SCoVAG) which had recommended using Vaxzevria for Sarawak eligible population on a voluntary basis.

“The vaccine will be supplied to Sarawak through the coordination of the National COVID-19 Immunisation Task Force (National CITF) and will be offered to the eligible population on a voluntary ‘first come, first served’ – by appointment basis,” CITF Sarawak said.

It said separate designated vaccination centres would be set up and prepared to provide the AstraZeneca vaccine to those who agreed to accept it and their operations would be announced in due time.

“SCoVAG had recommended the use of the vaccine among those above 60 years old in the urban areas, based on the very low overall severe adverse events of 6.5 per million doses and the high benefit to risk ratio among those above 60 years old,” it said.

CITF Sarawak said the state had initially opted not to include AstraZeneca for its COVID-19 vaccination plan following the fear and hesitancy among the public after the federal government announced that the vaccine would be part of the nationwide immunisation plan

Following this situation, the federal government decided to take the vaccine out of the plan and offered it to those who volunteered to have it on the ‘first come, first served’ basis, which had received overwhelming responses in Selangor and Kuala Lumpur.

An online survey was also conducted by a Sarawak news portal which had shown that 69.4 per cent of 1,037 respondents were in favour of having the AstraZeneca vaccine given to Sarawakians, while 52.9 per cent of 1,040 respondents wanted to be vaccinated with it.

“Given this new insight and willingness of the people in Sarawak to have the choice of the AstraZeneca vaccine, the CITF Sarawak has agreed to let the vaccine be used in Sarawak on a voluntary, ‘first come, first served’ basis,” CITF Sarawak added.

Source: BERNAMA

Adib Mohd

Recent Posts

TV Sarawak Is Leveling Up, From Kuching to the World with Spotlight 25/26

Since its debut in 2020, TV Sarawak (TVS) has been rewriting what it means to… Read More

15 hours ago

Skechers Steps Up the Game with New Basketball Collection

Skechers, The Comfort Technology Company™ and a global leader in lifestyle and performance footwear, has… Read More

15 hours ago

LexisNexis Brings AI Legal Sidekick to Malaysia with Protégé

Move over Suits, the future of law just got an AI upgrade. LexisNexis has officially… Read More

15 hours ago

BJAK Turns Insurance Renewals into Rewards with RM100,000 Mega Giveaway This 10.10

Renewing insurance and road tax is often a last-minute hassle, but BJAK, Malaysia’s largest online… Read More

20 hours ago

SHANTEA Dessert Opens First Outlet at Mid Valley, Serving Malaysian Culture Through Sweet Creations Ahead of Visit Malaysia 2026

Malaysian flavors stepped into the spotlight today as SHANTEA Dessert officially opened its first outlet… Read More

20 hours ago

Energea Powers Up Malaysia with Bold Tangerine Collection and Next-Gen Hybrid-Solid State Powerbank

Energea, the lifestyle-driven power solutions and tech accessories brand, has officially introduced two groundbreaking innovations:… Read More

20 hours ago

This website uses cookies.